After pausing for safety concerns, AstraZeneca and Johnson & Johnson have resumed their U.S. vaccine trials.
After pausing for safety concerns, AstraZeneca and Johnson & Johnson have resumed their U.S. vaccine trials.
NYTimes.com
0 shares
1 views
You might like
Related news coverage
Two Major Coronavirus Vaccine Trials Have Restarted After Being Paused For Safety Investigations
Upworthy
Johnson & Johnson and AstraZeneca will resume their coronavirus vaccine trials in the US after pauses to investigate unexplained...
-
AstraZeneca resuming US testing of COVID-19 vaccine
SeattlePI.com
-
Pfizer hopes to produce 100mln COVID-19 vaccine doses before 2021
Proactive Investors
-
Why pause in Covid-19 vaccine trials may be a good sign
IndiaTimes
-
Coronavirus treatment trials halted over safety concerns
CBS News
Advertisement
More coverage
Johnson & Johnson Covid-19 Vaccine On Hold
Newsy
Watch VideoThe race for an approved COVID-19 vaccine is dealing with a setback. Johnson & Johnson has paused their late stage..
-
US stocks end lower as potential coronavirus treatments hit a roadblock
Proactive Investors
-
2nd COVID-19 vaccine trial paused over unexplained illness
SeattlePI.com